{"schema_version":"secwatch.filing_event.v1","accession":"0001822479-25-000012","form_type":"8-K","ticker":"SHC","cik":"0001822479","company_name":"Sotera Health Co","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.080975+00:00","generated_at":"2026-05-26T02:26:28.296997+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sotera Health FY2024 revenue up 4.9% to $1.10B; net income down to $44M; provides 2025 outlook","bullets":["Q4 net revenues down 6.5% to $290M; net income $12M ($0.04 EPS) vs $39M ($0.14 EPS) in Q4 2023.","Full-year net revenues $1.10B (+4.9%); net income $44M ($0.16 EPS) vs $51M ($0.18 EPS) in 2023.","Adjusted EBITDA $549M (+3.9% YoY); Adjusted EPS $0.70 (down $0.02 YoY).","2025 guidance: net revenue growth 4.0%-6.0%, Adjusted EBITDA growth 4.5%-6.5% constant currency.","CEO highlights 19th consecutive year of revenue growth, >80% customer satisfaction, Sterigenics expansion, Nelson Labs growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001822479-25-000012","json":"https://secwatch.observer/filing/0001822479-25-000012.json","markdown":"https://secwatch.observer/filing/0001822479-25-000012.md","text":"https://secwatch.observer/filing/0001822479-25-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822479/000182247925000012/0001822479-25-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822479/000182247925000012/shc-20250227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T02:26:28.296997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}